Anthelmintic efficacy evaluation against different developmental stages of Ascaridia galli following individual or group administration in artificially trickle-infected chickens

Abstract

<p>The efficacy of commercially available anthelmintics against mature and immature stages (including ovicidal effects) of two Australian field isolates of <i>Ascaridia galli</i> was evaluated in two separate experiments. The anthelmintics tested were levamisole (LEV), piperazine (PIP) and flubendazole (FBZ) plus LEV-PIP. A total of 192 artificially trickle-infected young cockerels (96 birds per isolate) were randomized into sixteen experimental groups of 12 cockerels each (7 treatments and 1 untreated control per isolate). Chickens received label-recommended doses of LEV (28 mg/kg), PIP (100 mg/kg) or LEV-PIP co-administered at their full individual doses as a single oral dose or in group drinking water at recommended concentrations of 0.8 mg/ml or 2.5 mg/ml over eight hours for 1 and 2 days respectively and FLBZ (30 ppm) in the feed over 7 days. Anthelmintic efficacies were assessed by worm count reduction (WCR%) and excreta egg count reduction (EECR%) estimated by two methods. Ten days post treatment, all untreated control birds harboured mixed worm population of 10.1 and 12.3/bird for each isolate respectively which was significantly higher (P < 0.0001) than counts in all treatment groups. Luminal or histotrophic larvae comprised 50–57 % of the total worm count. For LEV, PIP and LEV-PIP, individual oral administration provided a somewhat higher efficacy than group medication in drinking water. EECR% values were inconsistent with WCR% and found to be only an indicator of efficacy against adult worms. All developmental stages of the two <i>A. galli</i> isolates were highly susceptible to FLBZ (100 %) followed by LEV-PIP (92.4–100 %) and LEV (87.7–100 %). PIP exhibited good efficacy against adult worms (92–97 %) but reduced efficacy against luminal (79–84 %) and histotrophic (61–72 %) larvae. Embryonation capacity of eggs recovered from worms expelled after treatment with LEV (47–54 %), PIP (44–54 %) or LEV-PIP (45–48 %) did not differ from those from untreated birds (50–51 %) whereas eggs from FLBZ treated worms had a significantly lower (P < 0.05) capacity to embryonate (≤ 2 %). Put together, our results demonstrate no evidence of resistance of the test <i>A. galli</i> isolates to the tested anthelmintics but a significant advantage of FLBZ, followed by LEV-PIP and LEV over PIP in the control of <i>A. galli</i>, specifically with regard to immature stages. <i>A. galli</i> worms expelled after treatment with LEV, PIP or their combination, but not FLBZ contain viable eggs. This has epidemiological implications and may also provide an option for isolating eggs from mature worms for <i>A. galli</i> propagation experiments without having to sacrifice birds.</p>